A depletion of the LMP2 subunit in PC-3 (prostate cancer cell line) has a growth inhibitory effect, supporting LMP2 as a novel target in conditions with an impaired process of apoptosis [4]. The gene discussed is PSMB9; the disease is prostate carcinoma.